The chart below shows how WM performed 10 days before and after its earnings report, based on data from the past quarters. Typically, WM sees a -0.61% change in stock price 10 days leading up to the earnings, and a +2.38% change 10 days following the report. On the earnings day itself, the stock moves by -0.54%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Legacy Business EBITDA Milestone: Operating EBITDA growth of more than 10% in the legacy business for 2024, achieving a full year operating EBITDA margin of 30% for the first time in history.
Operating EBITDA Growth: The collection and disposal business achieved a 10.4% growth in operating EBITDA in 2024, with a record margin of 37.2%, resulting in nearly $700 million in operating EBITDA growth.
Cash Flow Growth: Cash flow from operations grew more than 14% to $5.39 billion, while free cash flow before sustainability growth investments reached $3.27 billion, marking a 22.5% increase over 2023.
Acquisition Synergies and Growth: The successful completion of the Stericycle acquisition is expected to contribute $100 million in synergies in 2025, with the WM Healthcare Solutions business projected to grow about 9% before synergies.
EBITDA Growth Projection: Total company operating EBITDA growth is expected to reach 15% in 2025, translating to nearly $1 billion of growth compared to 2024.
Negative
EBITDA Growth vs. Tax Credit Loss: Operating EBITDA growth of 10% in the legacy business was overshadowed by a $63 million headwind from the expiration of alternative fuel tax credits, impacting overall profitability.
Operating Expenses Increase: Operating expenses as a percentage of revenue were 60.3%, indicating a slight increase in operational costs despite previous improvements, which could pressure margins in the future.
Increased Compensation Costs: The addition of Stericycle resulted in increased incentive compensation costs and higher employee health and welfare costs, negatively impacting margins by approximately 30 basis points.
Industrial Business Challenges: The industrial business remains soft, with no expected rebound in 2025, indicating ongoing challenges in capturing volume and revenue in this segment.
Increased Cash Interest Expenses: The company anticipates a $100 million increase in cash interest expenses in 2025, primarily due to the Stericycle acquisition, which will further strain financial performance.
Earnings call transcript: Waste Management Q4 2024 misses EPS forecast
WM.N
0.4%